Status:
UNKNOWN
ElectroMagnetic-guided Interstitial Catheter Navigation for Gynecological brachyTherapy
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Cervical Cancer
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Phase I study evaluating the feasibility of using electromagnetic navigation (EMN) for the catheter implantation procedure required of cervical brachytherapy. The addition of EMN to the current HDR br...
Detailed Description
Cervical cancer poses a significant local and global health problem. In 2017 over 1,500 Canadian women were predicted to develop cervical cancer, and another 400 were approximated to die from the dise...
Eligibility Criteria
Inclusion
- Women diagnosed with FIGO stage IB2-IVA (locally advanced) cervical cancer being treated with combined 3D interstitial / intracavitary HDR brachytherapy in 4 fractions and concurrent chemotherapy
- Minimum of 2 brachytherapy implantation procedures.
- The Syed-Neblett applicator is indicated for use due to the extent/complexity of the disease
- Given informed consent to take part in the study
Exclusion
- Metastatic disease
- Bilateral or unilateral hip prostheses
- Pacemakers
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03781271
Start Date
October 1 2019
End Date
February 1 2021
Last Update
March 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5